Explore News By Topic
03/02/2017
Study by PCF-Young Investigator identifies how cancer cells may develop resistance to FGFR inhibitors
Columbus, Ohio - A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor... Read More
02/14/2017
Prostate Cancer Foundation Announces New Recipients of 2016 PCF Challenge Awards to Promote Research in Deadly Prostate Cancer
SANTA MONICA, CA Feb. 14, 2017 – The Prostate Cancer Foundation (PCF) today announced that it has granted eight new 2016 PCF Challenge Awards to advance treatments and cures for metastatic or currently incurable prostate cancer. PCF Challenge Awards are multi-year awards supporting cross-disciplinary teams of research scientists. In 2016,... Read More
02/13/2017
PCF-Funded Research at the Cleveland Clinic Identifies how to Reverse Prostate Cancer Drug Resistance
A Cleveland Clinic research team has uncovered a biological pathway that renders a common prostate cancer drug useless and, for the first time, restored the drug’s cancer-killing power in human prostate cancer tumor cells grown in mice. Results from the study were published online today in the medical journal, eLife.... Read More
01/25/2017
PCF Statement On Nomination Of Dr. David Shulkin As VA Secretary
SANTA MONICA, CA—January 25, 2016—President and CEO of the of the Prostate Cancer Foundation, Dr. Jonathan W. Simons, MD, today released the following statement regarding President Donald J. Trump’s nominee to be secretary of the U.S. Department of Veterans Affairs (VA). Dr. Shulkin is currently serving as the undersecretary for... Read More
01/05/2017
Roswell Park Research Helps Explain Why Androgen-Deprivation Therapy Doesn’t Work for Many Prostate Cancers
BUFFALO, N.Y. (Roswell Park Cancer Institute) — Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. In new research published in the journal Science, Roswell Park Cancer Institute scientists have identified two gatekeeper genes that allow prostate cancer to progress and resist treatment. Their work... Read More
12/20/2016
Breast Cancer Research Foundation and Prostate Cancer Foundation Announce Their Commitment to Support the Blood Profiling Atlas in Cancer
In alignment with VP Biden’s Cancer Moonshot initiative, the Blood PAC formed in October 2016 to support progress towards patient benefit through research. Read More
12/08/2016
Prostate Cancer Foundation Statement on the Historic 21st Century Cures Act
The Prostate Cancer Foundation (PCF) applauds Congress and the White House for the strong, bipartisan show of support for the 21st Century Cures Act (H.R. 34). Following the Senate’s passage by a vote of 94 to 5, Congressional leaders signed the bill at this morning’s Enrollment Ceremony. The House had previously passed the game-changing medical innovation... Read More
12/01/2016
Holiday Cards Commemorating Musician Dan Fogelberg Now Available Sales Will Benefit The Prostate Cancer Foundation
PR Newswire, SANTA MONICA, CA December 1, 2016 The (PCF) announces that holiday cards designed by Jean Fogelberg in memory of her husband, musician Dan Fogelberg, are now available for purchase. Fogelberg passed away from prostate cancer in 2007 at the age of 56. A portion of sales will be... Read More
11/29/2016
VA Partners with Prostate Cancer Foundation to Expand Clinical Research
https://vimeo.com/737338762/0ec24693c4 WASHINGTON – As a national leader in oncology advancement and as the largest integrated healthcare system in the nation, the Department of Veterans Affairs (VA) today announced an important and substantial partnership with the Prostate Cancer Foundation (PCF) to prevent, screen and promote research to speed the development of... Read More
10/24/2016
Genetic Counseling Center Dedicated To Advanced Prostate Cancer Opens In Seattle
Prostate cancer is one of the most heritable forms of cancer. Hereditary mutations in “DNA repair” genes – BRCA1, BRCA2, and others – which are best known for their association with breast and ovarian cancer predisposition, are now known to be associated with advanced prostate cancer. In fact, ~12% of... Read More